A Message to the Proponents of Animal Experimentation: The Truth Shall Make you Free

Abstract

Some thoughts provoked by a ruling by the Advertising Standards Authority

Get full access to this article

View all access options for this article.

References

Anon. (2015). Complaint against UK anti-vivisection group ad upheld. LabAnimal Europe 15(2), 4.

Anon. (2014). ASA Adjudication on The National Antivivisection Society Ltd, 6pp. London, UK: Advertising Standards Authority. Available at: http://asa.org.uk/Rulings/Adjudications/2014/12/The-National-Anti_Vivisection-Society-Ltd/SHP_ADJ_272715.aspx#.VP7PhmdyaUk (Accessed 12.03.15).

I want to state at the outset that I do not have, and have never had, any kind of relationship with the NAVS. I did once have a meeting with them, at their premises, then in Harley Street, probably in the 1980s, after the passage of the Animals (Scientific Procedures) Act 1986, when they said that they didn't like me or FRAME and wanted nothing whatsoever to do with us.

Anon. (2007). Toxicity Testing in the 21st Century: A Vision and a Strategy. Report of the National Research Council Committee on Toxicity Testing and Assessment of Environmental Agents, 216pp. Washington, DC, USA: National Academies Press.

Bailey

, Thew

& Balls

(2013). An analysis of the use of dogs in predicting human toxicology and drug safety. ATLA 41, 335–350.

Bailey

, Thew

& Balls

(2014). An analysis of the use of animal models in predicting human toxicology and drug safety. ATLA 42, 181–199.

Pound

& Bracken

M.B.

(2014). Is animal research sufficiently evidence based to be a cornerstone of biomedical research? British Medical Journal 348, g3387.

Coleman

(2015). Likelihood ratios in assessing the safety of new medicines. ATLA 43, P2–P4.

Heinonen

(2015). Better science with human cell-based organ and tissue models. ATLA 43, 29–38.

10.

Anon. (2007). Overview of the National Research Council Toxicity Testing Strategy, 1pp. Washington, DC, USA: US Environmental Protection Agency. Available at: http://www.epa.gov/pesticides/science/nrc-toxtesting.html (Accessed 12.03.15).

11.

Bhogal

& Combes

(2006). TGN1412: Time to change the paradigm for the testing of new pharmaceuticals. ATLA 34, 225–239.

12.

Anon. (2006). Expert Group on Phase One Clinical Trials: Final Report, 107pp. London, UK: The Stationery Office. Available at: www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4141039&chk=Qczxoq (Accessed 12.03.15).

13.

Balls

(2014). Animal experimentation and alternatives: Time to say goodbye to the Three Rs and hello to humanity? ATLA 42, 327–333.

14.

Balls

(2014). Animal experimentation: Transparency and openness mean little, unless accompanied by honesty and accountability. ATLA 42, 157–160.

15.

King James Bible (1611). St John 8: 32, London, UK: Church of England.

16.

Anon. (2015). Wikipedia: Veritas vos liberabit. San Francisco, CA, USA: Wikimedia Foundation, Inc. Available at: http://en.wikipedia.org/wiki/Veritas_vos_liberabit (Accessed 12.03. 15).

17.

King James Bible (1611). St John 18: 38, London, UK: Church of England.

18.

Hudson-Shore

(2014). Statistics of Scientific Procedures on Living Animals 2013: Experimentation continues to rise — the reliance on genetically-altered animals must be addressed. ATLA 42, 261–266.

19.

I apologise for the unintended pun here — the pain suffered by the animals being used is clearly different from that of those who advocate the fastest possible development, validation and acceptance of non-animal methods.

20.

Goldacre

(2012). Alzheimer's is losing the battle — to marketing. The Times, 24 September. Available at: http://www.thetimes.co.uk/tto/opinion/columnists/article3547415.ece (Accessed 12.03.15).

21.

Goodman

(2015). Alzheimer's a curse that big pharma forgot. The Sunday Times, 28 February. Available at: http://www.thesundaytimes.co.uk/sto/business/Companies/article1524929.ece (Accessed 12.03.15).